Thai Physicians’ Perceptions of Sources of Information About New Drugs in Terms of Amounts of Information and Trustworthiness
Keywords:
information sources, new drugs, physicians, trustworthinessAbstract
Objective: To determine Thai physicians’ opinions of sources of information about new drugs regarding amounts of
information and the trustworthiness of the sources.
Methods: Questionnaires developed by the research team were sent to physicians working at each regional/general hospital
(92 totals) of the Ministry of Public Health in Thailand asking them to indicate the amount of information about new drugs
from different sources and the trustworthiness of the sources. Multiple regression analysis was used to determine variables
that related to the trustworthiness of information sources.
Results: One hundred and thirty (28.26%) of 460 questionnaires were returned. These indicated that in terms of amounts of
new information, Thai physicians received most from academic conferences, followed by medical journals, and medical
representatives respectively. Information from conferences was considered to be most trustworthy followed by information
from medical schools and experts. In contrast, information from medical representatives, direct mail advertisements, and
hospital pharmacists had low trustworthiness. After controlling for the variables of gender, education, and type of hospital,
multiple regression analysis found that the only significant factor was the relationship between age and trustworthiness of
information from the source of medical journals (standardized β = 0.199, p = 0.039). There was no factor that significantly
related to trustworthiness of information from other sources.
Conclusion: Thai physicians received information about new drugs from both commercial and professional sources but
trusted information from the latter more. This was considered appropriate as studies had found that information from
commercial sources was sometimes inaccurate, incomplete and misleading
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.